title: Long-term follow-up of immunotherapy-unresponsive recurrent tumefactive demyelination.
authors: Center of Neuroimmunology, Service of Neurology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.
authors: Delon
authors: D
authors: La Puma
authors: Center of Neuroimmunology, Service of Neurology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.
authors: Sara
authors: S
authors: Llufriu
authors: Center of Neuroimmunology, Service of Neurology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.
authors: Maria
authors: M
authors: Sepúlveda
authors: Center of Neuroimmunology, Service of Neurology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.
authors: Yolanda
authors: Y
authors: Blanco
authors: Department of Pathology, Hospital Clinic and Universitat de Barcelona, Barcelona, Spain.
authors: Teresa
authors: T
authors: Ribalta
authors: Center of Neuroimmunology, Service of Neurology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain.
authors: Francesc
authors: F
authors: Graus
authors: Center of Neuroimmunology, Service of Neurology, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Universitat de Barcelona, Barcelona, Spain. Electronic address: asaiz@clinic.ub.es.
authors: Albert
authors: A
authors: Saiz
mesh_terms: D003711:Demyelinating Diseases / Q000188:drug therapy / Q000473:pathology; D005500:Follow-Up Studies; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000473:pathology; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
keywords: Chemotherapy; Demyelinating disease; Immunotherapy; MRI; Multiple sclerosis; Tumefactive